董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Alexander Rabinovich | 男 | Chairman of the Board and Chief Executive Officer | 54 | 82.60万 | 未持股 | 2025-04-29 |
| David Salton | 男 | Director | 65 | 14.30万 | 0.87 | 2025-04-29 |
| Lennie Grinbaum | 女 | External Director | 49 | 14.80万 | 1.55 | 2025-04-29 |
| Gideon Hirschfeld | 男 | External Director | 59 | 未披露 | 0.87 | 2025-04-29 |
| Alon Granot | 男 | Director | 63 | 未披露 | 0.47 | 2025-04-29 |
| Lennie Michelson Grinbaum | 女 | External Director | 49 | 未披露 | 未持股 | 2025-04-29 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Alexander Rabinovich | 男 | Chairman of the Board and Chief Executive Officer | 54 | 82.60万 | 未持股 | 2025-04-29 |
| Amos Cohen | 男 | Chief Financial Officer | 45 | 212.60万 | 43.12 | 2025-04-29 |
董事简历
中英对照 | 中文 | 英文- Alexander Rabinovich
-
Alexander Rabinovich于2017年4月加入我们的董事会。他拥有纳斯达克（Nasdaq）和TASE上市公司的重要上市公司经验。Rabinovich先生目前是Green Forest Holdings Ltd.的首席执行官和董事，该公司是一家独资公司，从事资本投资。他曾担任Pilat Media Global plc（在TASE和伦敦证券交易所另类投资市场上市的上市公司，以及Visualety Systems Ltd等其他几家私人公司）的董事。Rabinovich先生拥有海法大学（University of Haifa）的经济学和会计学学士学位。
Alexander Rabinovich joined Board of Directors in April 2017. Mr. Rabinovich has served on the board of directors of Intercure Ltd. since October 2018, and as Chairman of Intercure's Board since February 2025 and is also the Chief Executive Officer of InterCure. He has significant public company experience with both Nasdaq and TASE listed companies. Mr. Rabinovich is currently also the Chief Executive Officer and director of Green Fields Capital Ltd., a public company listed on the TASE, engaged in investments in renewable energies. Mr. Rabinovich also served until 2014, on the board of directors of Pilat Media Global PLC, a public company listed on TASE and on the Alternative Investment Market of the London Stock Exchange. Mr. Rabinovich holds a B.A. degree in economics and accounting from the University of Haifa, Israel. - Alexander Rabinovich于2017年4月加入我们的董事会。他拥有纳斯达克（Nasdaq）和TASE上市公司的重要上市公司经验。Rabinovich先生目前是Green Forest Holdings Ltd.的首席执行官和董事，该公司是一家独资公司，从事资本投资。他曾担任Pilat Media Global plc（在TASE和伦敦证券交易所另类投资市场上市的上市公司，以及Visualety Systems Ltd等其他几家私人公司）的董事。Rabinovich先生拥有海法大学（University of Haifa）的经济学和会计学学士学位。
- Alexander Rabinovich joined Board of Directors in April 2017. Mr. Rabinovich has served on the board of directors of Intercure Ltd. since October 2018, and as Chairman of Intercure's Board since February 2025 and is also the Chief Executive Officer of InterCure. He has significant public company experience with both Nasdaq and TASE listed companies. Mr. Rabinovich is currently also the Chief Executive Officer and director of Green Fields Capital Ltd., a public company listed on the TASE, engaged in investments in renewable energies. Mr. Rabinovich also served until 2014, on the board of directors of Pilat Media Global PLC, a public company listed on TASE and on the Alternative Investment Market of the London Stock Exchange. Mr. Rabinovich holds a B.A. degree in economics and accounting from the University of Haifa, Israel.
- David Salton
-
David Salton自2014年12月起担任InterCure Ltd.的独立董事。他在生命科学行业的投资银行、投资公司和基金以及初创公司方面拥有超过25年的管理经验。除InterCure外，Salton先生还担任Aran Ltd.的独立董事。TASE：1085265和SHL远程医疗有限公司（SHLTN：SIX）。自2019年10月以来，Salton先生一直担任Vilrility Medical的首席执行官，这是一家开发消费医疗设备的初创公司。2009年至2019年9月，Salton先生担任Dentack Implants Ltd.的首席执行官兼总裁。Salton先生曾担任投资公司DCL Technologies Ltd.（之前在TASE上市）和公共非上市风险基金Leumi Star Ltd.的首席执行官。Salton先生还曾担任以下私营公司的首席执行官：Dyn-Bioshaf Ltd.、Darely Pharmaceutical Ltd.和DYN诊断控股-2000 Ltd.，并担任多家在TASE上市的公司的董事会成员。Salton先生还担任Leumi Partners的副总经理兼投资部门负责人，管理着1亿美元的资产和25家不同部门的投资组合公司。Salton先生拥有以色列工业工程学院Technion的经济学和管理学学士学位。
David Salton,has served as Chief Executive Officer of AnchorMesh Ltd., a start-up company developing orthopedic implants. He also serves as an external director of Anabella Medical Ltd. and Giza-Singer-Even Underwriting Ltd., public-non-listed, reporting Israeli companies. From May 2022 to February 2024, he had served as an independent director of SHL Telemedicine Ltd. (Nasdaq:SHLT). From February 2016 to February 2025, Mr. Salton served as an independent director of ARAN Research & Development (1982) Ltd. (TASE: ARAN). From October 2019 to October 2024, he served as Chief Executive Officer, President, and a member of the board of directors of Virility Medical, a startup company, developing consumer medical devices. Before that, from 2009 to September 2019, Mr. Salton served as Chief Executive Officer and President of Dentack Implants Ltd. Mr. Salton also has previously served as the Chief Executive Officer of DCL Technologies Ltd., an investment company (previously listed on TASE), and of Leumi Star Ltd., a public-non-listed venture fund. Mr. Salton also served as Chief Executive Officer of the following private companies: Dyn-Bioshaf Ltd., Darely Pharmaceutical Ltd., and DYN Diagnostics Holdings (2000) Ltd. Mr. Salton also served as the Deputy General Manager and Head of Investments Sector for Leumi Partners, with $100 million under management and 25 portfolio companies in various sectors. Mr. Salton holds a B.Sc., Economics & Management degree from the Technion, Industrial Engineering faculty, Israel. - David Salton自2014年12月起担任InterCure Ltd.的独立董事。他在生命科学行业的投资银行、投资公司和基金以及初创公司方面拥有超过25年的管理经验。除InterCure外，Salton先生还担任Aran Ltd.的独立董事。TASE：1085265和SHL远程医疗有限公司（SHLTN：SIX）。自2019年10月以来，Salton先生一直担任Vilrility Medical的首席执行官，这是一家开发消费医疗设备的初创公司。2009年至2019年9月，Salton先生担任Dentack Implants Ltd.的首席执行官兼总裁。Salton先生曾担任投资公司DCL Technologies Ltd.（之前在TASE上市）和公共非上市风险基金Leumi Star Ltd.的首席执行官。Salton先生还曾担任以下私营公司的首席执行官：Dyn-Bioshaf Ltd.、Darely Pharmaceutical Ltd.和DYN诊断控股-2000 Ltd.，并担任多家在TASE上市的公司的董事会成员。Salton先生还担任Leumi Partners的副总经理兼投资部门负责人，管理着1亿美元的资产和25家不同部门的投资组合公司。Salton先生拥有以色列工业工程学院Technion的经济学和管理学学士学位。
- David Salton,has served as Chief Executive Officer of AnchorMesh Ltd., a start-up company developing orthopedic implants. He also serves as an external director of Anabella Medical Ltd. and Giza-Singer-Even Underwriting Ltd., public-non-listed, reporting Israeli companies. From May 2022 to February 2024, he had served as an independent director of SHL Telemedicine Ltd. (Nasdaq:SHLT). From February 2016 to February 2025, Mr. Salton served as an independent director of ARAN Research & Development (1982) Ltd. (TASE: ARAN). From October 2019 to October 2024, he served as Chief Executive Officer, President, and a member of the board of directors of Virility Medical, a startup company, developing consumer medical devices. Before that, from 2009 to September 2019, Mr. Salton served as Chief Executive Officer and President of Dentack Implants Ltd. Mr. Salton also has previously served as the Chief Executive Officer of DCL Technologies Ltd., an investment company (previously listed on TASE), and of Leumi Star Ltd., a public-non-listed venture fund. Mr. Salton also served as Chief Executive Officer of the following private companies: Dyn-Bioshaf Ltd., Darely Pharmaceutical Ltd., and DYN Diagnostics Holdings (2000) Ltd. Mr. Salton also served as the Deputy General Manager and Head of Investments Sector for Leumi Partners, with $100 million under management and 25 portfolio companies in various sectors. Mr. Salton holds a B.Sc., Economics & Management degree from the Technion, Industrial Engineering faculty, Israel.
- Lennie Grinbaum
-
Lennie Grinbaum自2015年9月起在InterCure董事会担任外部董事。Grinbaum女士作为合同专家在合同研究组织方面拥有丰富的经验，并曾在以色列一家大型金融机构的子公司工作。Grinbaum女士拥有跨学科中心Hertzliya的法学学士学位和商业学士学位，以及伦敦帝国理工学院金融专业的MBA学位。
Lennie Grinbaum has served on Intercure's board of directors as an External Director since September 2015. Ms Grinbaum has in depth experience in Contract Research Organisation as a contract specialist and has worked for a subsidiary of a major Israeli financial institution. Ms Grinbaum holds an LLB in Law and a BA in Business from The Interdisciplinary Center Hertzliya as well as an MBA specializing in finance from Imperial College London. - Lennie Grinbaum自2015年9月起在InterCure董事会担任外部董事。Grinbaum女士作为合同专家在合同研究组织方面拥有丰富的经验，并曾在以色列一家大型金融机构的子公司工作。Grinbaum女士拥有跨学科中心Hertzliya的法学学士学位和商业学士学位，以及伦敦帝国理工学院金融专业的MBA学位。
- Lennie Grinbaum has served on Intercure's board of directors as an External Director since September 2015. Ms Grinbaum has in depth experience in Contract Research Organisation as a contract specialist and has worked for a subsidiary of a major Israeli financial institution. Ms Grinbaum holds an LLB in Law and a BA in Business from The Interdisciplinary Center Hertzliya as well as an MBA specializing in finance from Imperial College London.
- Gideon Hirschfeld
-
Gideon Hirschfeld于2018年加入InterCure董事会，担任外部董事。Hirschfeld先生在多家公司的业务发展方面拥有丰富的经验，例如以色列邮政，他在2009年7月至2016年3月期间担任以色列篮球超级联赛管理局和Academon Stores Ltd.的营销和业务发展总监。在加入InterCure董事会之前，Gideon发起了以技术为基础的产品和服务的合资企业，主要在物流和分销领域。Hirschfeld先生在与当前运营以及短期和长期财务计划相关的财务事项方面有着良好的记录。Hirschfeld先生拥有耶路撒冷希伯来大学的MBA学位和教育硕士学位以及两个国际关系和政治学学士学位。
Gideon Hirschfeld,has extensive experience in business development for various corporations, such as the Israel Post, where he served as Director, Marketing and Business Development, from July 2009 until March 2016, the Israeli Basketball Super League Administration and Academon Stores Ltd. Prior to joining InterCure's board, Gideon initiated joint ventures for technology-based products and services, mainly in the logistics and distribution fields. Mr. Hirschfeld has a proven track record in financial matters related to current operations and short and long-range financial plans. Mr. Hirschfeld holds an MBA from Heriot-Watt University, Edinburgh, Scotland, Master of Education (M.Ed.) from the Kibbutzim College, Tel-Aviv, Israel, and a B.A. in international relations and political science from the Hebrew University of Jerusalem, Israel. - Gideon Hirschfeld于2018年加入InterCure董事会，担任外部董事。Hirschfeld先生在多家公司的业务发展方面拥有丰富的经验，例如以色列邮政，他在2009年7月至2016年3月期间担任以色列篮球超级联赛管理局和Academon Stores Ltd.的营销和业务发展总监。在加入InterCure董事会之前，Gideon发起了以技术为基础的产品和服务的合资企业，主要在物流和分销领域。Hirschfeld先生在与当前运营以及短期和长期财务计划相关的财务事项方面有着良好的记录。Hirschfeld先生拥有耶路撒冷希伯来大学的MBA学位和教育硕士学位以及两个国际关系和政治学学士学位。
- Gideon Hirschfeld,has extensive experience in business development for various corporations, such as the Israel Post, where he served as Director, Marketing and Business Development, from July 2009 until March 2016, the Israeli Basketball Super League Administration and Academon Stores Ltd. Prior to joining InterCure's board, Gideon initiated joint ventures for technology-based products and services, mainly in the logistics and distribution fields. Mr. Hirschfeld has a proven track record in financial matters related to current operations and short and long-range financial plans. Mr. Hirschfeld holds an MBA from Heriot-Watt University, Edinburgh, Scotland, Master of Education (M.Ed.) from the Kibbutzim College, Tel-Aviv, Israel, and a B.A. in international relations and political science from the Hebrew University of Jerusalem, Israel.
- Alon Granot
-
ALON 格拉诺自2020年11月起在InterCure公司董事会任职，自2019年2月起在CannDoc公司董事会任职。Granot先生于2019年9月至2020年12月担任CannDoc的首席执行官。从2001年到2018年，Granot先生担任Frutarom Industries Ltd.（简称Frutarom）的副总裁兼副总裁，领导并购、业务发展和整体财务管理，直到2018年以约71亿美元的价格收购Frutarom。2008年至2016年，Granot先生担任Inter Industries Ltd.的外部董事，该公司在TASE公开交易。1998年至2001年，他还担任纳斯达克上市公司Kulicke & Soffa Industries，Inc.半导体部门的董事。Granot先生拥有学士学位。海法大学经济学和工商管理学士，以色列理工学院经济学和工商管理硕士学位。
Alon Granot,has served on InterCure's board of directors since November 2020 and Canndoc's board of directors since February 2019. Mr. Granot served as Canndoc's Chief Executive Officer from September 2019 to December 2020. From July 2021 to August 2023, Mr. Granot also served as a director at Aura Smart Air Ltd. (TASE: AUSA). From 2001 to 2018, Mr. Granot served as Chief Financial Officer and Executive Vice President at Frutarom Industries Ltd. ("Frutarom"), where he led mergers and acquisitions, business development and overall financial management until Frutarom was acquired for approximately $7.1 billion in 2018. From 2008 to 2016, and from August 2019 to January 2021, Mr. Granot served as an external director and independent director at Inter Industries Ltd.(TASE: ININ). He also served as director in the semiconductor division of Kulicke & Soffa Industries, Inc., a public company listed on Nasdaq, from 1998 to 2001. Mr. Granot holds a B.A. in economics and business administration from Haifa University and received an M.A. in economics and business administration from Technion-Israel Institute of Technology, Israel. - ALON 格拉诺自2020年11月起在InterCure公司董事会任职，自2019年2月起在CannDoc公司董事会任职。Granot先生于2019年9月至2020年12月担任CannDoc的首席执行官。从2001年到2018年，Granot先生担任Frutarom Industries Ltd.（简称Frutarom）的副总裁兼副总裁，领导并购、业务发展和整体财务管理，直到2018年以约71亿美元的价格收购Frutarom。2008年至2016年，Granot先生担任Inter Industries Ltd.的外部董事，该公司在TASE公开交易。1998年至2001年，他还担任纳斯达克上市公司Kulicke & Soffa Industries，Inc.半导体部门的董事。Granot先生拥有学士学位。海法大学经济学和工商管理学士，以色列理工学院经济学和工商管理硕士学位。
- Alon Granot,has served on InterCure's board of directors since November 2020 and Canndoc's board of directors since February 2019. Mr. Granot served as Canndoc's Chief Executive Officer from September 2019 to December 2020. From July 2021 to August 2023, Mr. Granot also served as a director at Aura Smart Air Ltd. (TASE: AUSA). From 2001 to 2018, Mr. Granot served as Chief Financial Officer and Executive Vice President at Frutarom Industries Ltd. ("Frutarom"), where he led mergers and acquisitions, business development and overall financial management until Frutarom was acquired for approximately $7.1 billion in 2018. From 2008 to 2016, and from August 2019 to January 2021, Mr. Granot served as an external director and independent director at Inter Industries Ltd.(TASE: ININ). He also served as director in the semiconductor division of Kulicke & Soffa Industries, Inc., a public company listed on Nasdaq, from 1998 to 2001. Mr. Granot holds a B.A. in economics and business administration from Haifa University and received an M.A. in economics and business administration from Technion-Israel Institute of Technology, Israel.
- Lennie Michelson Grinbaum
-
Lennie Michelson Grinbaum，还曾担任Parkomat International Ltd.（TASE：PRKM）的外部董事。Michelson Grinbaum女士作为合同专家在Contract Research Organization拥有丰富的经验，曾任职于以色列一家大型金融机构的子公司。Michelson Grinbaum女士拥有跨学科中心Hertzliya的法学法学学士学位和商学学士学位，以及英国伦敦帝国理工学院的金融专业MBA学位。
Lennie Michelson Grinbaum,has also served as an external director of Parkomat International Ltd. (TASE: PRKM). Ms. Michelson Grinbaum has in depth experience in Contract Research Organization as a contract specialist and has worked for a subsidiary of a major Israeli financial institution. Ms. Michelson Grinbaum holds an LLB in Law and a BA in Business from The Interdisciplinary Center Hertzliya as well as an MBA specializing in finance from Imperial College London, U.K.. - Lennie Michelson Grinbaum，还曾担任Parkomat International Ltd.（TASE：PRKM）的外部董事。Michelson Grinbaum女士作为合同专家在Contract Research Organization拥有丰富的经验，曾任职于以色列一家大型金融机构的子公司。Michelson Grinbaum女士拥有跨学科中心Hertzliya的法学法学学士学位和商学学士学位，以及英国伦敦帝国理工学院的金融专业MBA学位。
- Lennie Michelson Grinbaum,has also served as an external director of Parkomat International Ltd. (TASE: PRKM). Ms. Michelson Grinbaum has in depth experience in Contract Research Organization as a contract specialist and has worked for a subsidiary of a major Israeli financial institution. Ms. Michelson Grinbaum holds an LLB in Law and a BA in Business from The Interdisciplinary Center Hertzliya as well as an MBA specializing in finance from Imperial College London, U.K..
高管简历
中英对照 | 中文 | 英文- Alexander Rabinovich
Alexander Rabinovich于2017年4月加入我们的董事会。他拥有纳斯达克（Nasdaq）和TASE上市公司的重要上市公司经验。Rabinovich先生目前是Green Forest Holdings Ltd.的首席执行官和董事，该公司是一家独资公司，从事资本投资。他曾担任Pilat Media Global plc（在TASE和伦敦证券交易所另类投资市场上市的上市公司，以及Visualety Systems Ltd等其他几家私人公司）的董事。Rabinovich先生拥有海法大学（University of Haifa）的经济学和会计学学士学位。
Alexander Rabinovich joined Board of Directors in April 2017. Mr. Rabinovich has served on the board of directors of Intercure Ltd. since October 2018, and as Chairman of Intercure's Board since February 2025 and is also the Chief Executive Officer of InterCure. He has significant public company experience with both Nasdaq and TASE listed companies. Mr. Rabinovich is currently also the Chief Executive Officer and director of Green Fields Capital Ltd., a public company listed on the TASE, engaged in investments in renewable energies. Mr. Rabinovich also served until 2014, on the board of directors of Pilat Media Global PLC, a public company listed on TASE and on the Alternative Investment Market of the London Stock Exchange. Mr. Rabinovich holds a B.A. degree in economics and accounting from the University of Haifa, Israel.- Alexander Rabinovich于2017年4月加入我们的董事会。他拥有纳斯达克（Nasdaq）和TASE上市公司的重要上市公司经验。Rabinovich先生目前是Green Forest Holdings Ltd.的首席执行官和董事，该公司是一家独资公司，从事资本投资。他曾担任Pilat Media Global plc（在TASE和伦敦证券交易所另类投资市场上市的上市公司，以及Visualety Systems Ltd等其他几家私人公司）的董事。Rabinovich先生拥有海法大学（University of Haifa）的经济学和会计学学士学位。
- Alexander Rabinovich joined Board of Directors in April 2017. Mr. Rabinovich has served on the board of directors of Intercure Ltd. since October 2018, and as Chairman of Intercure's Board since February 2025 and is also the Chief Executive Officer of InterCure. He has significant public company experience with both Nasdaq and TASE listed companies. Mr. Rabinovich is currently also the Chief Executive Officer and director of Green Fields Capital Ltd., a public company listed on the TASE, engaged in investments in renewable energies. Mr. Rabinovich also served until 2014, on the board of directors of Pilat Media Global PLC, a public company listed on TASE and on the Alternative Investment Market of the London Stock Exchange. Mr. Rabinovich holds a B.A. degree in economics and accounting from the University of Haifa, Israel.
- Amos Cohen
Amos Cohen自2020年3月起担任InterCure的首席财务官。Cohen先生拥有超过15年的财务和商业经验，包括担任TASE上市公司Trendline Information and Communication Services Ltd.的首席财务官。Cohen先生还曾担任以色列最大的电信公司Walla a Bazek Group Entity的财务副总裁，以及以色列最大的电视频道Reshet的FP & A董事。科恩先生拥有学士学位。本古里安大学经济学学士，管理学术研究学院会计学硕士。
Amos Cohen,has over 17 years of financial and business experience, including as the CFO of Trendline Information and Communication Services Ltd., a TASE-listed company. Mr. Cohen has also served as the VP of finance at Walla (a Bezeq group entity, which is the biggest telecommunications company in Israel) and as a director of FP&A at Reshet, the largest TV channel is Israel. Mr. Cohen holds a B.A. in economics from Ben-Gurion University and received an M.A. in accounting from College of Management Academic Studies, Israel.- Amos Cohen自2020年3月起担任InterCure的首席财务官。Cohen先生拥有超过15年的财务和商业经验，包括担任TASE上市公司Trendline Information and Communication Services Ltd.的首席财务官。Cohen先生还曾担任以色列最大的电信公司Walla a Bazek Group Entity的财务副总裁，以及以色列最大的电视频道Reshet的FP & A董事。科恩先生拥有学士学位。本古里安大学经济学学士，管理学术研究学院会计学硕士。
- Amos Cohen,has over 17 years of financial and business experience, including as the CFO of Trendline Information and Communication Services Ltd., a TASE-listed company. Mr. Cohen has also served as the VP of finance at Walla (a Bezeq group entity, which is the biggest telecommunications company in Israel) and as a director of FP&A at Reshet, the largest TV channel is Israel. Mr. Cohen holds a B.A. in economics from Ben-Gurion University and received an M.A. in accounting from College of Management Academic Studies, Israel.